| Therapeutic Agent |
Action |
|
|
1) Drugs inhibiting thyroid hormone synthesis, release
or peripheral
conversion of T4 to T3. |
|
| Thionamides |
Inhibition of iodide orgnification |
| (methimazole, |
Inhibition of coupling of iodotyrosines |
| propylthiouracil, |
Inhibition of T4 to T3 conversion (PTU) |
| carbimazole) |
|
|
| Iodide |
Inhibition of iodide oxidation and |
| (Lugol's solution, SSKI) |
organification |
|
Inhibition of thyroid hormone release |
|
Decreased thyroid vascularity |
|
|
| Iodinated constrast |
Inhibition of T4 to T3 conversion |
| agents(iopanoic acid, |
Release of inorganic iodide and consequent |
| sodium ipodate) |
inhibition of thyroid hormone synthesis and secretion |
|
|
| Potassium perchlorate |
Competitive inhibition of iodide pump |
|
(inhibition of iodide uptake and consequent release of iodide from
the thyroid) |
| Glucocorticoids |
Inhibition of thyroid hormone secretion (efficiency unknown) |
|
Inhibition of peripheral conversion of T4 to T3 |
|
|
|
|
2) Drugs inhibiting the effects of thyroid hormones
on peripheral tissues |
|
|
| Beta-adrenergic |
Inhibition of adrenergic effects of thyroid |
| antagonists (propranolol, |
hormones |
| metoprolol, nadolol) |
Inhibition of peripheral conversion of T4 (atenolol, bisoprolol) |
|
to T3 (propranolol) |
|
|
| Calcium antagonists |
Anti-arrhythmic effect and reduction of heart (diltiazem, verapamil)
rate |
|
|
|
|
| 3) Ablative forms of treatment. |
|
|
| Radioactive iodide |
Destruction of thyroid follicular cells by beta radiation |
|
|
| Surgery |
Removal of tissue responsible for excessive secretion of thyroid hormones |
|
|